Tramadol can cause seizures even at normal doses, especially in older adults, those with seizure history, or those taking certain antidepressants. Learn who's most at risk and what to do about it.
Combining insulin and beta-blockers can mask hypoglycemia symptoms, putting diabetic patients at high risk for dangerous low blood sugar events. Learn how to recognize the hidden signs and reduce your risk.
Metabolic surgery offers the most effective path to lasting weight loss and type 2 diabetes remission, with studies showing over 30% of patients remain in remission 15 years after surgery. Learn who benefits most, what to expect, and why so few eligible patients get it.
Tetracyclines can stain children's teeth, but doxycycline is now proven safe for short courses. Learn why the guidelines changed, which antibiotics are still risky, and what parents need to know in 2026.
Sleep medications for seniors often cause falls, confusion, and memory loss. Safer alternatives like CBT-I, low-dose doxepin, and ramelteon offer better results without the risks. Learn what to avoid and what actually works.
Learn how to spot and report dangerous medication errors in elderly patients. From polypharmacy risks to reporting tools like the ombudsman and MEDMARX, this guide gives families actionable steps to protect seniors from preventable harm.
Biologic drugs are made from living cells and can't be copied exactly like small-molecule generics. Their complex manufacturing, batch variability, and strict regulations make biosimilars the only viable alternative - not true copies.
Patient decision aids improve medication safety by helping patients understand treatment options, reduce decisional conflict, and increase adherence. Evidence shows they boost knowledge, align choices with personal values, and cut errors-especially for chronic conditions.
Mast cell activation releases harmful mediators that cause chronic symptoms like hives, brain fog, and anaphylaxis. Mast cell stabilizers like cromolyn sodium block this release, offering relief for MCAS patients-though they require consistent use and don't work for everyone.
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, driving development of life-saving medicines that would otherwise be too costly to produce. Learn how it works, who benefits, and why it's here to stay.
Isotretinoin can cause depression in some users, but the absolute risk is low. Learn how to monitor your mental health during treatment, recognize warning signs, and make informed decisions with your doctor.
The global generic drug market is set to grow rapidly through 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India and China's manufacturing power, and regulatory shifts are reshaping access to affordable medicines worldwide.
FDA warning letters are serious enforcement actions targeting manufacturing violations of CGMP rules. Learn what triggers them, how to respond, and the real costs of ignoring them.
Regulatory capture occurs when government agencies prioritize industry interests over public welfare. Learn how revolving doors, lobbying, and information asymmetry weaken regulation - and what you can do about it.